1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Egypt, Israel, Lebanon & Saudi Arabia: Clinical Development Profile

Egypt, Israel, Lebanon & Saudi Arabia: Clinical Development Profile

  • February 2014
  • -
  • Industry Standard Research
  • -
  • 62 pages

Finding patients to participate in clinical trials is a constant struggle in the pharmaceutical industry. The challenging nature of recruitment leads both sponsors and service providers to consistently explore new geographies to find appropriate patient populations. The largest CROs have made several recent acquisitions and agreements in the Middle East and North Africa region which may indicate that clinical trial activity in the area is poised to increase.

In this report, ISR provides insight into the clinical trial regulation and development environment, sponsor and service provider activities, and population “health status” for Egypt, Israel, Lebanon, and Saudi Arabia. Consider this report a “primer” for learning about clinical trials in the region.

Report Overview

Finding patients to participate in clinical trials is a constant struggle in the pharmaceutical industry. The challenging nature of recruitment leads both sponsors and service providers to consistently explore new geographies to find appropriate patient populations. The largest CROs have made several recent acquisitions and agreements in the Middle East and North Africa region which may indicate that clinical trial activity in the area is poised to increase. In this report, ISR provides insight into the clinical trial regulation and development environment, sponsor and service provider activities, and population “health status” for Egypt, Israel, Lebanon, and Saudi Arabia. Consider this report a “primer” for learning about clinical trials in the region.

What you will learn in this report:



How you can use this report:

• How population health status, regulations, clinical trial activity, and international and domestic company partnerships make Egypt, Israel, Lebanon, and Saudi Arabia some of the top emerging global pharmaceutical markets
• Insights from domestic service provider organizations on conducting clinical trials in Egypt, Israel, Lebanon and Saudi Arabia
• Clinical trial operational metrics for countryspecific clinical studies
• Compiled lists and contact details for domestic and international service providers
• Understand how Egypt, Israel, Lebanon, and Saudi Arabi compare to other countries on a variety of health condition scales so the reader can consider the areas in which they may be beneficial as trial sites
• Understand the legal, logistical, and regulatory details for conducting clinicals trials, and illustrate the benefits and drawbacks of conducting trials in Egypt, Israel, Lebanon, and Saudi Arabia

Table Of Contents

Egypt, Israel, Lebanon and Saudi Arabia: Clinical Development Profile
Table of Contents

Copyright and Usage Guidelines ..5
Methodology and Sources ...6
Introduction .7
Egypt ...8
Israel ...9
Lebanon 10
Saudi Arabia .11
Health Statistics .13
Clinical Trial Activity ...17
Egypt .18
Clinical trials, by Phase .19
Study type distribution 19
Industry-funded study type distribution .20
Average trial length, by Phase .20
Average enrollment, by Phase .21
Israel .22
Clinical trials, by Phase 23
Study type distribution 23
Industry-funded study type distribution .24
Average trial length, by Phase 24
Average enrollment, by Phase 25
Lebanon 26
Clinical trials, by Phase 27
Study type distribution 27
Industry-funded study type distribution .28
Average trial length, by Phase 28
Average enrollment, by Phase 29
Saudi Arabia .30
Clinical trials, by Phase ...31
Study type distribution (i.e. interventional) ...31
Industry-funded study type distribution 32
Average trial length, by Phase ...32
Average enrollment, by Phase ...33
Domestic CROs capabilities chart ..34
Domestic Clinical Service Providers ...39
Atlas Medical Services ..40
Background / History ...40
Jordan Center for Pharmaceutical Research 41
Background / History ...41
MCT ..42
Background / History ..42
Company profile responses 43
Geographic reach ...44
Therapeutic expertise ..45
Experience by Phase 45
Triumpharma 46
Background / History ...46
IPRC ..47
Background / History ...47
Acdima BioCenter .48
Background / History ...48
Pharmaceutical Research Unit .49
Background / History ..49
Molecule CRO ..50
Background / History .50
MEK Consulting 51
Background / History ..51
Therapeutic experience ..51
Therapeutic experience by Phase ...52
Regional experience 52
Organizational structure ..53
Clients and studies ...53
CRA education ..54
CRA experience 54
ClinServ .55
Background / History ...55
Nagy Research ...56
Background / History ...56
Examples of clients ..56
SCIDRE Co. .57
Background / History ...57
Clinart MENA 58
Background / History ...58
Company progress ...58
Interventional studies ..59
Observational studies ...59
Domestic Service Provider Contact List .60
About Industry Standard Research 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

Clinical Trial Imaging Market by Product & Services, Modality, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global clinical trial imaging market is projected to reach USD 1069.7 million by 2021 from USD 773.4 million in 2016, at a CAGR of 6.7% from 2016 to 2021. Increase in R&D spending and growth in the ...

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)

  • $ 5274
  • Industry report
  • September 2016
  • by Industry ARC

Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse ...

Global Clinical Trials Market

December 2016 $ 4250

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.